Research Article
Further Validation of a Rapid Screening Semiquantitative Thin-Layer Chromatographic Method for Marketed Antimalarial Medicines for Adoption in Malawi
Table 4
Comparison of quality of some antimalarial medicines by SQ-TLC and HPLC.
| Code | Manufacturer’s label claim (mg) | SQ-TLC results | HPLC results | Quality of individual API components in the order presented in label claim | Quality of the sample as a whole | Quality of individual API components in the order presented in label claim | Quality of the sample as a whole |
| 24Y13 | ATS/SDX/PYR: 100/500/25 | BLC | NC | C | NC | C | NC | C | NC | 2X15 | ATM/LUM: 20/120 | NC | C | NC | NC | C | NC | 24X14 | ATM/LUM: 20/120 | NC | NC | NC | NC | NC | NC | 12X14 | ATM/LUM: 20/120 | NC | C | NC | NC | C | NC | 23Z1 | DHA/SDX/PYR: 60/500/25 | NC | C | C | NC | NC | C | C | NC | 23Z1 | DHA/SDX/PYR: 60/500/25 | NC | C | C | NC | NC | C | C | NC | 14P10 | SDX/PYR: 500/25 | NC | C | NC | NC | C | NC | 13Z1 | DHA/SDX/PYR: 60/500/25 | NC | BLC | C | NC | NC | NC | C | NC | 35Z1 | DHA/SDX/PYR: 60/500/25 | NC | BLC | C | NC | NC | NC | C | NC | 16Z1 | DHA/PPQ: 40/320 | C | — | C | C | — | C | 11V5 | QUN: 50 mg/5 mL | C | C | C | — | C | 4V5 | QUN: 50 mg/5 mL | BLC | BLC | BLC | BLC | 42Y12 | ATS/SM/PYR: 200/500/25 | C | — | C | C | C | — | NC | NC | 19X1 | ATM/LUM: 80/480 | C | BLC | BLC | C | NC | NC | 21X1 | ATM/LUM: 20/120 | C | BLC | BLC | C | NC | NC | 11P2 | SDX/PYR: 500/25 | BLC | BLC | BLC | NC | NC | NC | 12Z3 | DHA/PPQ: 40/320 | BLC | — | BLC | NC | — | NC | 12V5 | QUN: 50 mg/5 mL | BLC | BLC | NC | NC | 13V5 | QUN: 50 mg/5 mL | C | C | BLC | BLC |
|
|